Although most clinicians instinctively try to avoid prescribing multiple medications concurrently, there is evidence that polypharmacy is increasing. Some estimates suggest up to 65% of U.S. adults ...

Polypharmacy was associated with a nearly doubled increase in health care expenditures and a tripled increase in pharmacy expenditures among older patients with cardiovascular diseases (CVD).

The share of patients meeting the definition of polypharmacy for the condition of overactive bladder declined from 2006 to 2017, but the phenomenon was still prevalent in women and patients in nursing ...

Patients with NSCLC taking five or more medications tended to have worse survival, highlighting the need for medication management, research showed. Older patients with advanced non-small cell lung ...

If you've heard the term "polypharmacy" used to talk about medication recently, you're not alone. But what is it, and are there risks? Below, experts discuss the oft-disputed definition of the term.

A total of 56.2% of Danish patients with dementia experienced polypharmacy — using five or more prescription drugs, according to a February study published in Alzheimer’s Research & Therapy. The study ...

In patients with acute HF, polypharmacy is common and associated with multimorbidity and older age. Polypharmacy is common globally among patients with acute heart failure (HF) and is associated with ...

In today’s healthcare system, we stand at a critical crossroads when it comes to medication management. For decades, the practice of polypharmacy — prescribing multiple drugs to treat various symptoms ...

Big heap of various pills and tablets packs and blisters. High quality 3d render Five years ago, my 21-year-old son Bradley died of psychiatric drug interactions, after years of battling anxiety, ...

About half of older adults hospitalized with heart failure (HF) take at least 10 medications and that proportion is increasing over time, according to a new study. "I felt this was an opportunity to ...

Depression and EGFR mutation status in stage IV non-small cell lung cancer. Background: To evaluate the prevalence of polypharmacy and the inappropriate prescribing of medications (IPM), and to ...